PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 µM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 µM, respectively), PAT-1251 is used in the research of fibrotic diseases[1].
Molecular Weight:
399.34
Purity:
99.52
CAS Number:
[2007885-39-2]
Formula:
C18H17F4N3O3
Target:
Monoamine Oxidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
